Truist Securities Downgrades OrthoPediatrics to Hold, Lowers Price Target to $31
Portfolio Pulse from Benzinga Newsdesk
Truist Securities analyst Kaila Krum has downgraded OrthoPediatrics (NASDAQ:KIDS) from Buy to Hold and reduced the price target from $39 to $31.

January 25, 2024 | 11:43 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
OrthoPediatrics was downgraded by Truist Securities from Buy to Hold, and the price target was lowered from $39 to $31.
The downgrade from Buy to Hold suggests that Truist Securities sees limited upside potential or increased risk in OrthoPediatrics' stock. The reduction in the price target further implies a bearish outlook on the stock's value, which could lead to a negative short-term impact on the stock price as market sentiment adjusts to the new analyst rating and price target.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100